HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 34 filers reported holding HORIZON PHARMA INVT LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | 0.0% | 29,000 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -99.9% | 29,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $2,915,000 | +10310.7% | 29,000 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | +3.7% | 29,000 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | 0.0% | 29,000 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | +3.8% | 29,000 | 0.0% | 0.00% | – |
| Q3 2017 | $26,000 | +4.0% | 29,000 | 0.0% | 0.00% | – |
| Q2 2017 | $25,000 | -98.8% | 29,000 | -98.7% | 0.00% | -100.0% |
| Q1 2017 | $2,025,000 | -58.7% | 2,200,000 | -57.7% | 0.00% | -60.0% |
| Q4 2016 | $4,905,000 | +0.0% | 5,200,000 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $4,904,000 | +2.9% | 5,200,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $4,765,000 | +8.3% | 5,200,000 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $4,398,000 | – | 5,200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|